The drug costs patients 129,000. The same cost for patients in other countries about a third of that amount. I realize the pharmaceutical Companies Invest their researches, they bring a new drug to market, they should profit from that innovation, but why are the u. S. Patients getti getting gauged for drugs. Can you better explain why u. S. Taxpayers are paying for Biomedical Research at the front end and paying exorbitant prices at the back end . Ill just say that 50 of my colleagues and myself sent a letter to you and secretary burwell requesting that they write when taxpair funded research leads to patent product not available to the public on reasonable terms . What are reasonable terms . A drug shouldnt cost 129,000 for people to get access to it. I know this is a topic of great interest, and while it should be and my heart goes out as all of us do to patients who are in need of a therapeutic which is outside of their financial means to be able to gain access to. That ought to be
A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person's white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels.
Rutgers Spinoff Creates Handheld White Blood Cell Tracker miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researchers develop a handheld white blood cell tracker medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Researcher, Through Spinoff, Develops a Handheld White Blood Cell Tracker newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.